CTSL and celiac disease: We suggest this protein as a leading candidate glutenase for the development of oral medical preparations that fight CD and gluten intolerance in susceptible people (patent application No. 2023115446 “Obtaining Recombinant Acid-Stable Cathepsin L (Mutant Form) and Methods of Its Application”, Federal Service for Intellectual Property, Russia).